Total Payments
$54,742
2024 Payments
$91.87
Companies
9
Transactions
61
Medicare Patients
1,231
Medicare Billing
$244,263
Payment Breakdown by Category
Other$35,448 (64.8%)
Consulting$10,115 (18.5%)
Travel$7,738 (14.1%)
Food & Beverage$1,422 (2.6%)
Education$19.81 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $35,448 | 15 | 64.8% |
| Consulting Fee | $10,115 | 4 | 18.5% |
| Travel and Lodging | $7,738 | 21 | 14.1% |
| Food and Beverage | $1,422 | 20 | 2.6% |
| Education | $19.81 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $28,020 | 21 | $0 (2019) |
| Bayer HealthCare Pharmaceuticals Inc. | $20,910 | 23 | $0 (2019) |
| AbbVie, Inc. | $5,251 | 11 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $137.92 | 1 | $0 (2019) |
| Seattle Genetics, Inc. | $107.86 | 1 | $0 (2017) |
| Janssen Biotech, Inc. | $105.85 | 1 | $0 (2019) |
| Secura Bio, Inc. | $98.45 | 1 | $0 (2020) |
| ADC Therapeutics America, Inc. | $91.87 | 1 | $0 (2024) |
| Merck Sharp & Dohme LLC | $19.81 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $91.87 | 1 | ADC Therapeutics America, Inc. ($91.87) |
| 2023 | $19.81 | 1 | Merck Sharp & Dohme LLC ($19.81) |
| 2020 | $98.45 | 1 | Secura Bio, Inc. ($98.45) |
| 2019 | $14,508 | 19 | Celgene Corporation ($7,314) |
| 2018 | $25,435 | 26 | Bayer HealthCare Pharmaceuticals Inc. ($19,210) |
| 2017 | $14,589 | 13 | Celgene Corporation ($14,481) |
All Payment Transactions
61 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/08/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $91.87 | General |
| 02/23/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Education | In-kind items and services | $19.81 | General |
| Category: ONCOLOGY | ||||||
| 02/25/2020 | Secura Bio, Inc. | Farydak (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $98.45 | General |
| Category: Oral Oncologic | ||||||
| 09/16/2019 | Bayer HealthCare Pharmaceuticals Inc. | Aliqopa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,700.00 | General |
| Category: Oncology | ||||||
| 08/22/2019 | AbbVie, Inc. | Venclexta (Drug) | Consulting Fee | Cash or cash equivalent | $4,050.00 | General |
| Category: Virology | ||||||
| 08/22/2019 | AbbVie, Inc. | Venclexta (Drug) | Travel and Lodging | In-kind items and services | $100.43 | General |
| Category: Virology | ||||||
| 08/22/2019 | AbbVie, Inc. | Venclexta (Drug) | Travel and Lodging | In-kind items and services | $44.94 | General |
| Category: Virology | ||||||
| 08/09/2019 | AbbVie, Inc. | Venclexta (Drug) | Travel and Lodging | In-kind items and services | $533.60 | General |
| Category: Virology | ||||||
| 08/09/2019 | AbbVie, Inc. | Venclexta (Drug) | Travel and Lodging | In-kind items and services | $86.67 | General |
| Category: Virology | ||||||
| 08/09/2019 | AbbVie, Inc. | Venclexta (Drug) | Food and Beverage | In-kind items and services | $60.12 | General |
| Category: Virology | ||||||
| 08/09/2019 | AbbVie, Inc. | Venclexta (Drug) | Food and Beverage | In-kind items and services | $41.62 | General |
| Category: Virology | ||||||
| 08/09/2019 | AbbVie, Inc. | Venclexta (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Virology | ||||||
| 08/09/2019 | AbbVie, Inc. | Venclexta (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: Virology | ||||||
| 08/08/2019 | AbbVie, Inc. | Venclexta (Drug) | Travel and Lodging | In-kind items and services | $157.07 | General |
| Category: Virology | ||||||
| 08/08/2019 | AbbVie, Inc. | Venclexta (Drug) | Travel and Lodging | In-kind items and services | $139.56 | General |
| Category: Virology | ||||||
| 05/17/2019 | Celgene Corporation | Revlimid (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,850.00 | General |
| Category: Hematology / Oncology | ||||||
| 05/17/2019 | Celgene Corporation | Revlimid (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,977.50 | General |
| Category: Hematology / Oncology | ||||||
| 05/17/2019 | Celgene Corporation | Revlimid (Drug) | Travel and Lodging | In-kind items and services | $656.20 | General |
| Category: Hematology / Oncology | ||||||
| 05/17/2019 | Celgene Corporation | Revlimid (Drug) | Travel and Lodging | In-kind items and services | $265.07 | General |
| Category: Hematology / Oncology | ||||||
| 05/08/2019 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $137.92 | General |
| 05/03/2019 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $105.85 | General |
| Category: Oncology | ||||||
| 01/09/2019 | Celgene Corporation | Revlimid (Drug) | Consulting Fee | Cash or cash equivalent | $565.00 | General |
| Category: Hematology / Oncology | ||||||
| 10/15/2018 | Bayer HealthCare Pharmaceuticals Inc. | Aliqopa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,360.00 | General |
| Category: Oncology | ||||||
| 10/05/2018 | Bayer HealthCare Pharmaceuticals Inc. | Aliqopa (Drug) | Travel and Lodging | In-kind items and services | $465.75 | General |
| Category: Oncology | ||||||
| 10/04/2018 | Bayer HealthCare Pharmaceuticals Inc. | Aliqopa (Drug) | Food and Beverage | In-kind items and services | $62.92 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 237 | 562 | $145,154 | $49,159 |
| 2022 | 7 | 339 | 811 | $211,160 | $70,628 |
| 2021 | 7 | 348 | 854 | $214,578 | $72,854 |
| 2020 | 8 | 307 | 715 | $171,490 | $51,622 |
Total Patients
1,231
Total Services
2,942
Medicare Billing
$244,263
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 82 | 226 | $65,792 | $23,405 | 35.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 44 | 198 | $54,279 | $18,050 | 33.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 50 | 68 | $9,736 | $2,898 | 29.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 24 | 27 | $7,388 | $2,369 | 32.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 26 | 32 | $7,001 | $2,141 | 30.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 11 | $958.00 | $296.88 | 31.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 108 | 273 | $75,348 | $29,279 | 38.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 84 | 361 | $95,665 | $28,475 | 29.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 36 | 41 | $10,824 | $3,322 | 30.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 54 | 72 | $9,864 | $3,155 | 32.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 30 | 37 | $7,585 | $2,488 | 32.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 15 | 15 | $5,910 | $2,076 | 35.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 12 | 12 | $5,964 | $1,833 | 30.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 83 | 387 | $102,555 | $31,103 | 30.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 76 | 198 | $54,648 | $22,383 | 41.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 65 | 124 | $25,420 | $8,776 | 34.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 47 | 53 | $13,992 | $4,398 | 31.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 52 | 67 | $9,179 | $3,156 | 34.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 12 | 12 | $4,728 | $1,749 | 37.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 13 | 13 | $4,056 | $1,289 | 31.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 69 | 291 | $77,115 | $24,143 | 31.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 104 | 268 | $54,940 | $15,132 | 27.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 50 | 67 | $18,492 | $5,863 | 31.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 34 | 38 | $10,032 | $3,218 | 32.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 14 | 14 | $6,958 | $2,172 | 31.2% |
About Rafic Farah
Rafic Farah is a Medical Oncology healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780760587.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Rafic Farah has received a total of $54,742 in payments from pharmaceutical and medical device companies, with $91.87 received in 2024. These payments were reported across 61 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($35,448).
As a Medicare-enrolled provider, Farah has provided services to 1,231 Medicare beneficiaries, totaling 2,942 services with total Medicare billing of $244,263. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical Oncology
- Location Seattle, WA
- Active Since 10/27/2006
- Last Updated 05/24/2021
- Taxonomy Code 207RX0202X
- Entity Type Individual
- NPI Number 1780760587
Products in Payments
- Revlimid (Drug) $28,020
- Aliqopa (Drug) $20,910
- Venclexta (Drug) $5,251
- ADCETRIS (Biological) $107.86
- DARZALEX (Biological) $105.85
- Farydak (Drug) $98.45
- KEYTRUDA (Biological) $19.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Oncology Doctors in Seattle
Bart Scott
Medical Oncology — Payments: $1.5M
Medical Oncology $1.5M
Petros Grivas, M.d, M.D
Medical Oncology — Payments: $683,103
Medical Oncology $683,103
Evan Yu
Medical Oncology — Payments: $356,321
Medical Oncology $356,321
Gary Lyman, Md, MD
Medical Oncology — Payments: $176,021
Medical Oncology $176,021
Jerald Radich, Md, MD
Medical Oncology — Payments: $171,817
Medical Oncology $171,817
David Maloney
Medical Oncology — Payments: $167,323
Medical Oncology $167,323